Ken Griffin Ark Genomic Revolution ETF (De Transaction History
Citadel Advisors LLC
- $618 Billion
- Q3 2025
A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Ark Genomic Revolution ETF (De stock. As of the latest transaction made, Citadel Advisors LLC holds 694,200 shares of ARKG stock, worth $18.7 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
694,200
Previous 346,700
100.23%
Holding current value
$18.7 Million
Previous $8.44 Million
128.35%
% of portfolio
0.0%
Previous 0.0%
Shares
23 transactions
Others Institutions Holding ARKG
# of Institutions
297Shares Held
20.3MCall Options Held
2.53MPut Options Held
2.8M-
Jpmorgan Chase & CO New York, NY3.94MShares$106 Million0.01% of portfolio
-
Morgan Stanley New York, NY2.83MShares$76.2 Million0.0% of portfolio
-
Goldman Sachs Group Inc New York, NY2.16MShares$58.1 Million0.01% of portfolio
-
Citigroup Inc1.52MShares$40.8 Million0.02% of portfolio
-
Ubs Group Ag1.12MShares$30.1 Million0.01% of portfolio